- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Book Review: Anti-VEGF Use in Ophthalmology ; volume:3 ; number:1 ; day:4 ; month:9 ; year:2017 ; pages:1-2 ; date:12.2017
International Journal of Retina and Vitreous ; 3, Heft 1 (4.9.2017), 1-2, 12.2017
- Schlagwort
-
Augenheilkunde
Augenkrankheit
- Urheber
-
Vora, Robin A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-017-0086-7
- URN
-
urn:nbn:de:1111-2017102618168
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Rezension
Beteiligte
- Vora, Robin A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy